6.07 pm | 21 May 2013 |  Source: Moneycontrol.com

Venus Remedies has reported a sales standalone turnover of Rs 125.32 crore and a net profit of Rs 11.95 crore for the quarter ended Mar '13...

2.46 pm | 20 May 2013 |  Source: Moneycontrol.com

Venus Remedies at its meeting held on May 18, 2013, has recommended a dividend at 30% i.e. Rs 3 per share for the financial year ended March 31, 2013,...

11.53 am | 14 May 2013 |  Source: Moneycontrol.com

With reference to the earlier announcement dated May 09, 2013, regarding Board Meeting on May 18, 2013, Venus Remedies has now informed that the compa...

3.41 pm | 09 May 2013 |  Source: Moneycontrol.com

Venus Remedies board meeting will be held on May 18, 2013, to consider and approve the audited financial results for the quarter ended March 31, 2013a...

4.47 pm | 08 May 2013 |  Source: CNBC-TV18

Venus Remedies entered OTC (over-the-counter) category with Ezenus. Dheeraj Aggarwal, CFO, Venus Remedies says that Ezenus is our first OTC product wh...

2.38 pm | 06 May 2013 |  Source: Moneycontrol.com

Venus Remedies has been awarded Gold medal by DST – Lockheed Martin India Innovation Growth program – 2013 for ELORES, a drug designated to fight mult...

4.13 pm | 02 May 2013 |  Source: PTI

Pharma firm Venus Remedies today said it has signed a deal with South Korean drug company Goodwills Co Ltd for exclusive marketing of its antibiotic d...

3.58 pm | 02 May 2013 |  Source: Moneycontrol.com

Venus Remedies has outlicesed Elores to a South Korean Market leader after its patent grant from companies and intellectual property registration offi...